ZYDUS LIFESCIENCES
Back to Balance Sheet
|
ZYDUS LIFESCIENCES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹-542 Cr | ₹193 Cr | ₹-725 Cr | ₹-194 Cr | ₹19 Cr |
What is the latest Total Non-Current Liabilities ratio of ZYDUS LIFESCIENCES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹-542 Cr |
| Mar2024 | ₹193 Cr |
| Mar2023 | ₹-725 Cr |
| Mar2022 | ₹-194 Cr |
| Mar2021 | ₹19 Cr |
How is Total Non-Current Liabilities of ZYDUS LIFESCIENCES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-542 Cr | Negative | |
| Mar2024 | ₹193 Cr | Positive | |
| Mar2023 | ₹-725 Cr | Negative | |
| Mar2022 | ₹-194 Cr | Negative | |
| Mar2021 | ₹19 Cr | - | |
Compare Total Non-Current Liabilities of peers of ZYDUS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ZYDUS LIFESCIENCES | ₹94,809.2 Cr | 1.7% | -5.9% | -1.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹439,378.0 Cr | 2.8% | 6.7% | 2.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,996.0 Cr | 1.9% | -0.5% | 6.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹125,959.0 Cr | 0.1% | 3.4% | 15.8% | Stock Analytics | |
| CIPLA | ₹123,666.0 Cr | 1.8% | -3.2% | 2.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,008.0 Cr | 2.7% | 0.4% | 3.4% | Stock Analytics | |
ZYDUS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ZYDUS LIFESCIENCES | 1.7% |
-5.9% |
-1.6% |
| SENSEX | 0.6% |
1.3% |
7% |
You may also like the below Video Courses